In Brazil, where pertussis cases have climbed, mainly in infants <4 months of age, vaccinating pregnant women with Tdap vaccine at the same coverage rate as influenza vaccination in pregnant women (57%) would reduce pertussis cases in children under 1 year of age by 41%, deaths by 43%, and would be cost-effective, according to the WHO thresholds.
Full Citation:
Sartori AMC, de Soarez PC, Fernandes EG et al.. 2016. Cost-effectiveness analysis of universal maternal immunization with Tdap vaccine in Brazil. Vaccine. 34(13).
Title of Article: Cost-effectiveness analysis of universal maternal immunization with Tdap vaccine in Brazil
Author(s): Sartori AMC, de Soarez PC, Fernandes EG et al.
Publication Year: 2016
Publication Name: Vaccine
Publication Volume: 34(13)
Publication Source URL: https://pubmed.ncbi.nlm.nih.gov/26899375/
DOI (Digital Object Identifier): 10.1016/j.vaccine.2016.02.026
Topics: Economics & Return on Investment
Disease Vaccines: Pertussis
Countries: Brazil
WHO Regions: Americas